Advertisement

AIDS drug development wins economics award

Two economists from the University of Chicago won the linkurl:Eugene Garfield Economic Impact of Medical and Health Research Award;http://www.researchamerica.org/outreach/garfieldaward.html this month, given out by the advocacy group Research!America. linkurl:Tomas Philipson;http://harrisschool.uchicago.edu/faculty/web-pages/tomas-philipson.asp and linkurl:Anupam Jena;http://www.rand.org/economics/jena.html looked at how much consumers save and companies profit from the development of life-exten

By | October 23, 2007

Two economists from the University of Chicago won the linkurl:Eugene Garfield Economic Impact of Medical and Health Research Award;http://www.researchamerica.org/outreach/garfieldaward.html this month, given out by the advocacy group Research!America. linkurl:Tomas Philipson;http://harrisschool.uchicago.edu/faculty/web-pages/tomas-philipson.asp and linkurl:Anupam Jena;http://www.rand.org/economics/jena.html looked at how much consumers save and companies profit from the development of life-extending AIDS drugs. Each year, Garfield, who founded __The Scientist__ 21 years ago, gives $5,000 to people who have taken a close look at the impact medical research has on the economy. It's a tough question to answer, as I found out while reporting an linkurl:article;http://www.the-scientist.com/article/display/53302/ on the subject in __The Scientist__ this summer. The estimates of research?s impact on the economy vary widely, but one thing seems to be consistent: its impact appears positive. As Philipson and Jena found, for example, society gained $1.4 trillion from people?s lives being extended by AIDS drugs. The problem the authors find, however, is that companies are taking in just 5% of this "social surplus," raising concerns about the incentives companies have for innovation. You can read their study in the linkurl:Forum for Health Economics and Policy.;http://www.bepress.com/fhep/biomedical_research/3/
Advertisement
EMD Millipore
EMD Millipore

Popular Now

  1. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  2. First Data from Anti-Aging Gene Therapy
  3. Locating Language within the Brain
  4. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

Advertisement
SomaLogic
SomaLogic
Advertisement
RayBioTech